|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM365326801 |
| 003 |
DE-627 |
| 005 |
20250305124148.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202306852
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1217.xml
|
| 035 |
|
|
|a (DE-627)NLM365326801
|
| 035 |
|
|
|a (NLM)38041689
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Yao, Xuxiang
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a DNA Nanomaterial-Empowered Surface Engineering of Extracellular Vesicles
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 03.10.2024
|
| 500 |
|
|
|a Date Revised 03.10.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2023 Wiley‐VCH GmbH.
|
| 520 |
|
|
|a Extracellular vesicles (EVs) are cell-secreted biological nanoparticles that are critical mediators of intercellular communication. They contain diverse bioactive components, which are promising diagnostic biomarkers and therapeutic agents. Their nanosized membrane-bound structures and innate ability to transport functional cargo across major biological barriers make them promising candidates as drug delivery vehicles. However, the complex biology and heterogeneity of EVs pose significant challenges for their controlled and actionable applications in diagnostics and therapeutics. Recently, DNA molecules with high biocompatibility emerge as excellent functional blocks for surface engineering of EVs. The robust Watson-Crick base pairing of DNA molecules and the resulting programmable DNA nanomaterials provide the EV surface with precise structural customization and adjustable physical and chemical properties, creating unprecedented opportunities for EV biomedical applications. This review focuses on the recent advances in the utilization of programmable DNA to engineer EV surfaces. The biology, function, and biomedical applications of EVs are summarized and the state-of-the-art achievements in EV isolation, analysis, and delivery based on DNA nanomaterials are introduced. Finally, the challenges and new frontiers in EV engineering are discussed
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a DNA nanomaterials
|
| 650 |
|
4 |
|a DNA nanotechnology
|
| 650 |
|
4 |
|a biomarker
|
| 650 |
|
4 |
|a drug delivery
|
| 650 |
|
4 |
|a extracellular vesicles
|
| 650 |
|
7 |
|a DNA
|2 NLM
|
| 650 |
|
7 |
|a 9007-49-2
|2 NLM
|
| 700 |
1 |
|
|a He, Dongdong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wei, Pengyao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Niu, Zitong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Hao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Lin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Fu, Pan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Yiting
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lou, Saiyun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Qian, Sihua
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zheng, Jianping
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zuo, Guokun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Kaizhe
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 37 vom: 02. Sept., Seite e2306852
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnas
|
| 773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:37
|g day:02
|g month:09
|g pages:e2306852
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202306852
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 2024
|e 37
|b 02
|c 09
|h e2306852
|